Link between cardiac myosin binding protein-C gene mutation of Pro1208fs and Gly507 Arg and hypertrophic cardiomyopathy in Chinese patients.
- Author:
Min LI
1
;
Kuan CHENG
;
Qi-Bing WANG
;
Wen-Qing ZHU
;
Sheng-Mei QIN
;
Jie CUI
;
Xian-Hong SHU
;
Rui-Zhen CHEN
;
Jun-Bo GE
;
Hao-Zhu CHEN
Author Information
- Publication Type:Journal Article
- MeSH: Adolescent; Adult; Aged; Asian Continental Ancestry Group; genetics; Cardiomyopathy, Hypertrophic; genetics; Carrier Proteins; genetics; Case-Control Studies; Exons; Female; Genotype; Humans; Male; Middle Aged; Mutation; Phenotype; Young Adult
- From: Chinese Journal of Cardiology 2009;37(9):790-793
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo detect gene mutations associated with hypertrophic cardiomyopathy (HCM) in Chinese patients and possible correlations between genotype and phenotype.
METHODSTwenty-one unrelated patients with hypertrophic cardiomyopathy were studied. The clinical data including symptoms, physical examination, echocardiography and electrocardiography were collected. The full ecoding exons of cardiac myosin-binding protein C gene (cMYBPC3) were amplified with PCR and the products were sequenced.
RESULTSTwo mutations were identified in probands from two families. One mutation was frame shift mutation Pro1208fs in the exon 32 of the cMYBPC3 gene. Pro1208fs mutation was identified in a 59 years old female patient with familial hypertrophic cardiomyopathy. Symptom onset was late and a favorable clinical course was evidenced in this patient. Another mutation was missence mutation Gly507Arg in the exon 17 of the MYBPC3 gene identified in a 24 years old male patient. Diffuse thickness of left ventricular wall, impaired diastolic function and enlarged left atria were evidenced in echocardiography. No mutation was identified in the 80 control healthy individuals.
CONCLUSIONcMYBPC3 might be the disease-causing genes in Chinese patients with hypertrophic cardiomyopathy.